BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9573684)

  • 1. Therapy-related acute leukemia associated with involvement of 11q23 after high grade non-Hodgkin lymphoma.
    Martinelli G; Testoni N; Zinzani PL; Biondi A; Cimino G; Tura S
    Haematologica; 1998 Mar; 83(3):283-4. PubMed ID: 9573684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome translocations: good genes gone wrong.
    Rowley JD
    Pathol Biol (Paris); 1995 Mar; 43(3):197-201. PubMed ID: 7675546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
    Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
    Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin structural elements and chromosomal translocations in leukemia.
    Zhang Y; Rowley JD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal diet and infant leukemia: a role for DNA topoisomerase II inhibitors?
    Ross JA
    Int J Cancer Suppl; 1998; 11():26-8. PubMed ID: 9876473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
    Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
    Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.
    Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB
    Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia in infants.
    Felix CA; Lange BJ
    Oncologist; 1999; 4(3):225-40. PubMed ID: 10394590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukemias induced by anticancer chemotherapies].
    Harousseau JL
    Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
    Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
    Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood myeloid leukaemias.
    Hall GW
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):573-91. PubMed ID: 11640870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
    Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
    Lu Y; Xu W; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of acute myeloid leukemia.
    Caligiuri MA; Strout MP; Gilliland DG
    Semin Oncol; 1997 Feb; 24(1):32-44. PubMed ID: 9045303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial duplication of the MLL oncogene in patients with aggressive acute myeloid leukemia.
    Sambani C; La Starza R; Roumier C; Crescenzi B; Stavropoulou C; Katsarou O; Karafoulidou A; Dhalle JH; Lai JL; Preudhomme C; Martelli MF; Mecucci C
    Haematologica; 2004 Apr; 89(4):403-7. PubMed ID: 15075073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.